Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia (Q33838994)

29 July 2017

1 reference

title

Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia (English)

1 reference

29 July 2017

1 reference

Margolis DA

1

1 reference

PubMed ID

10676910

29 July 2017

Casper JT

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

Seminars in Hematology

1 reference

29 July 2017

37

1 reference

29 July 2017

43-55

1 reference

29 July 2017

1

1 reference

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Probability of finding HLA-matched unrelated marrow donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Nomenclature for factors of the HLA system, 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

What is in store after stem-cell transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

HLA class II nucleotide sequences, 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Treatment options in severe aplastic anaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2800%2990029-5

7 January 2021

10.1016/S0037-1963(00)90029-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10676910